Last September, Tidepool — a diabetes data management platform — was among the nine companies chosen to participate in the FDA’s experimental pre-certification program pilot.
from MobiHealthNews http://ift.tt/2FBRktI
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment